JEFFREY TAYLOR: Open Payments
NPI 1518329028 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,118 in 176 payments from 42 companies in 2025. Trend: 2023 $6,028 · 2024 $5,267 · 2025 $5,118
Food & beverage: $3,713Long term medical supply or device loan: $1,000Education: $405
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 30 | $1,309 |
| Merck Sharp & Dohme LLC | 9 | $434 |
| Janssen Biotech, Inc. | 13 | $387 |
| AstraZeneca Pharmaceuticals LP | 9 | $286 |
| E.R. Squibb & Sons, L.L.C. | 16 | $277 |
| Astellas Pharma US Inc | 7 | $210 |
| Daiichi Sankyo Inc. | 9 | $161 |
| PFIZER INC. | 6 | $133 |
| Regeneron Healthcare Solutions, Inc. | 4 | $122 |
| Celgene Corporation | 4 | $116 |
Products named: KISQALI, KEYTRUDA, ERLEADA, OPDIVO, ENHERTU, RYBREVANT, LIBTAYO, Trodelvy.
Industry payments across TN — which companies pay providers there.
